[1]赵 锐,石秀园,胡若飞,等.省域药品临床综合评价工作的关键环节探讨[J].卫生经济研究,2022,39(5):17-20.
 ZHAO Rui,SHI Xiu-yuan,HU Ruo-fei,et al.Discussion on the Key Links of Comprehensive Clinical Evaluation of Drugs in Provinces[J].Journal Press of Health Economics Research,2022,39(5):17-20.
点击复制

省域药品临床综合评价工作的关键环节探讨
分享到:

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
39
期数:
2022年5期
页码:
17-20
栏目:
药械管理
出版日期:
2022-04-27

文章信息/Info

Title:
Discussion on the Key Links of Comprehensive Clinical Evaluation of Drugs in Provinces
作者:
赵 锐1石秀园2胡若飞3刘春平1
1.国家卫生健康委卫生发展研究中心,北京 100044
2.深圳市卫生健康发展研究和数据管理中心,广东 深圳 518000
3.昆明医科大学,云南 昆明 650000
Author(s):
ZHAO Rui SHI Xiu-yuan HU Ruo-fei LIU Chun-ping
National Health Development Research Center, Beijing 100044, China
关键词:
药品临床综合评价评价机制关键环节省域实践
Keywords:
comprehensive clinical evaluation of drugs evaluation mechanism key link provincial practice
分类号:
R19
文献标志码:
A
摘要:
目的:分析省域药品临床综合评价工作实施现状和存在问题,探索标准化路径和可复制推广模式,以期为各地开展综合评价工作提供经验参考。方法:通过现场调研、访谈、座谈及文献研究等方式,梳理出各省药品临床综合评价的实施进展、问题与挑战。结果:先试先行省份在组织体系、运行机制、信息平台和保障机制等方面取得阶段性进展,主要问题聚焦于评价目标理解、信息共享、政府主导、评价制度、质量控制等关键环节。结论:各省应把握评价工作回归临床价值的核心要义,建立健全沟通协同机制、主题遴选机制、专业机构与人员准入管理机制、质量控制机制、信息共享机制以及多元结果转化应用机制。
Abstract:
Objective To analyze the implementation status of comprehensive clinical evaluation of drugs at provincial level in China, and to explore the standardized path and reproducible promotion model, in order to provide experience reference for comprehensive evaluation in various regions. Methods Through document and literature study, expert discussion, expert forum and so on, the implementation progress, blocking points and challenges of the current comprehensive clinical evaluation policy in each province were studied and sorted out. Results The pilot provinces have made progress in organizational system construction, information construction, guarantee mechanism and specific work. The main problems focus on the understanding of evaluation objectives, information sharing, government leadership, evaluation system, quality control and other key links. Conclusions In order to promote the implementation of comprehensive clinical evaluation policy of drugs in China and guide the standardized and orderly development of evaluation work in each province, it is suggested that all provinces should grasp the core meaning of regression of evaluation work to clinical value. It is suggested to establish and improve the communication and coordination mechanism, a mechanism for selecting topics within the province, professional institutions and personnel access management mechanism, the provincial management and technical quality control mechanism. It is recommended to strengthen information platform construction, establish information sharing mechanism, explore the establishment of multiple results transformation and application mechanism, and accelerate the evaluation of the national chess mode.

参考文献/References:

[1] 王晓玲.儿科呼吸系统药物临床综合评价的方法学建议[J].中国实用儿科杂志,2020,35(3):195-198.
[2] 严俊涛,魏艳,刘世蒙,等.国际框架对我国卫生技术评估制度化路径构建策略的启示[J].中国医疗保险,2022(1):75-80.
[3] NICE.Guide to the processes of technology appraisal[EB/OL].(2018-03-30)[2022-01-11].https://www.nice.org.uk/process/pmg19/chapter/acknowledgements.
[4] IQWiG.General Methods-Version 6-IQWiG[EB/OL]. https://www.iqwig.de/methoden/general-methods_version-6-0.pdf.
[5] Sherman RE,Anderson SA, Dal Pan GJ,et al.Real-world evidencewhat is it and what can it tell us?[J].N Engl J Med,2016,375(23):2293-2297.
[6] 石秀园,赵锐,李璠,等.构建我国药品临床综合评价工作机制的思考[J].中国药房,2020,31(23):2828-2833.
[7] 岳晓菲,张帆,刘跃华,等.英国NICE卫生技术评估流程的决策转化机制及启示[J].中国卫生经济,2021,40(1):91-96.
[8]国家卫生健康委.关于规范开展药品临床综合评价工作的通知[EB/OL].(2021-07-28)[2021-12-08].http://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f4869.shtml.
[9] 王海银,符雨嫣,覃肖潇,等.药品临床综合评价:保障临床基本用药合理使用[J].中国卫生,2021(8):72-73.
[10] 刘爱军,王韬,刘盾.智慧医院相关技术在医院建设中的应用[J].中华医院管理杂志,2020,36(9):754-756.

更新日期/Last Update: 2022-04-27